HealthSWEDE: costs with sublingual immunotherapy—a Swedish questionnaire study

@article{Olsson2021HealthSWEDECW,
  title={HealthSWEDE: costs with sublingual immunotherapy—a Swedish questionnaire study},
  author={Petter Olsson and Carl Skr{\"o}der and Lars Ahlbeck and Frida Hjalte and Karl-Olof Welin and Ulla Westin and Morgan Andersson and Cecilia Ahlstr{\"o}m-Emanuelsson and Lars Olaf Cardell},
  journal={Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology},
  year={2021},
  volume={17}
}
  • P. Olsson, Carl Skröder, L. Cardell
  • Published 8 June 2020
  • Medicine
  • Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Background The aim of this cross-sectional survey was to compare the health-economic consequences for allergic rhinitis (AR) patients treated with sublingual Immunotherapy (SLIT) in terms of direct and indirect costs with a reference population of patients receiving standard of care pharmacological therapy. Methods Primary objective was to analyse the health-economic consequences of SLIT for grass pollen allergy in Sweden vs reference group waiting for subcutaneous immunotherapy (SCIT). A… 
1 Citations

Update about Oralair® as a treatment for grass pollen allergic rhinitis

TLDR
Oralair® is a five-grass pollen SLIT tablet containing natural pollen allergens from five of the major grass species responsible for seasonal AR due to grass pollen allergy, a well-tolerated, safe, and effective approach to treating allergic rhinitis.

References

SHOWING 1-10 OF 25 REFERENCES

TOTALL: high cost of allergic rhinitis—a national Swedish population-based questionnaire study

TLDR
The total cost of allergic rhinitis in Sweden, with a population of 9.5 million, was estimated at €1.3 billion annually, with unexpectedly high costs could be related to the high prevalence of disease, in combination with the previously often underestimated indirect costs.

Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?

TLDR
The CMA indicates that SQ HDM SLIT-tablets are a cost-minimizing alternative to HDM SCIT when considered from a societal perspective in Ontario and Quebec.

Reduced work/academic performance and quality of life in patients with allergic rhinitis and impact of allergen immunotherapy

TLDR
AR (the persistent and more severe form of the disease) has an impact on functional characteristics of adult patients in Spain and AIT might reduce the effect of this disease on the work/academic performance and HRQOL.

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview

TLDR
Systematic reviews were undertook to critically assess evidence on the effectiveness, safety and cost‐effectiveness of AIT for these conditions and found gaps in the evidence.

Prevalence of Chronic Nasal Symptoms in West Sweden: Risk Factors and Relation to Self-Reported Allergic Rhinitis and Lower Respiratory Symptoms

TLDR
The prevalence of chronic nasal symptoms in West Sweden was found to be high and strongly associated both with self-reported allergic rhinitis and symptoms from the lower airways, including family history of allergy and asthma and smoking.

The Cost and Impact of Health Conditions on Presenteeism to Employers

TLDR
Health conditions are associated with on-the-job productivity losses and presenteeism is a major component of the total employer cost of those conditions, although the exact dollar amount cannot be determined at this time.

Economic burden of inadequate management of allergic diseases in the European Union: a GA2LEN review

TLDR
In the European Union, between 44 and 76 million individuals of the 217 million EU employees suffer from allergic disease of the airways or the skin, with major socio‐economic consequences such as absence from work (absenteeism), particularly reduced productivity at work (presenteeism).

Cost‐effectiveness of grass pollen allergen immunotherapy in adults

Major scientific societies, such as the EAACI or the AAAAI, do not express any suggestion on which form of allergen immunotherapy (AIT) is to be preferred (subcutaneous immunotherapy, SCIT, vs

Health, Absence, Disability, and Presenteeism Cost Estimates of Certain Physical and Mental Health Conditions Affecting U.S. Employers

TLDR
Evidence about the total cost of health, absence, short-term disability, and productivity losses was synthesized for 10 health conditions and the overall economic burden of illness was highest for hypertension, heart disease, and depression and other mental illnesses.